Fig. 1 · Structure
Documents & Downloads
D-Galactose pentaacetate
Insulin Release Inhibitor
D-Galactose pentaacetate is an insulin release inhibitor that specifically targets leucine-induced insulin secretion. This compound is valuable for studying persistent hyperinsulinemia in childhood and investigating insulinoma. Its ability to modulate insulin release makes it a useful tool in diabetes and metabolic disorder research.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 25878-60-8 |
| Applications | Insulin Release Inhibitor |
| Formula | C16H22O11 |
| Molecular Weight | 390.34 |
| Synonyms | Pentaacetyl-D-galactopyranose |
| SMILES | CC(O[C@H]1[C@H]([C@H](OC([C@@H]1OC(C)=O)OC(C)=O)COC(C)=O)OC(C)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.